Loading...
NYSE: COR
Cencora, Inc.
Healthcare · Medical - Distribution
●S&P 500 since 2001
Market Cap
$64.24B
52w High
$377.54
52w Low
$264.33
P/E
39.47
Volume
1.87M
Outstanding Shares
194.53M
Company profile
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.
CEORobert Mauch
SectorHealthcare
IndustryMedical - Distribution
Employees47,000
IPO dateApr 4, 1995
Valuation
Forward P/E—
EV/EBITDA17.91
Enterprise value$66.93B
Stock splits
Jun 13, 201410:1
Jun 16, 20092:1
Dec 29, 20052:1
Mar 25, 19992:1
Profitability & growth
Revenue growth5.45%
Gross margin3.28%▲6.62%vs FY2024
Operating margin1.19%▲9.76%vs FY2024
ROE103.06%▼55.89%vs FY2024
Analyst consensus
RatingBuy
Target price$408.00▲23.54%
33
Buy
12
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 6, 2026
View
EPS
Actual vs estimate by quarter
Q3FY25
ActualEst.
$4.00
$3.85
Q4FY25
ActualEst.
$3.84
$3.79
Q1FY26
ActualEst.
$4.08
$4.05
Q2FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q3FY25
ActualEst.
$80.66B
$80.09B
Q4FY25
ActualEst.
$83.73B
$83.46B
Q1FY26
ActualEst.
$85.93B
$86.06B
Q2FY26
Next Est.
—